Results 91 to 100 of about 4,101 (195)
Humoral immune response to different routes of myxomatosis vaccine application
The aim of our study was to monitor the dynamics of the serological response to different application routes of live attenuated myxomatosis vaccine. The study included 42 Californian breed rabbits, aged 3 mo, of both sexes.
I. Manev +3 more
doaj +1 more source
Innate Immunity Never “NODs” Off: NLRs Regulate the Host Anti‐Viral Immune Response
ABSTRACT A robust innate immune response is essential in combating viral pathogens. However, it is equally critical to quell overzealous immune signaling to limit collateral damage and enable inflammation resolution. Pattern recognition receptors are critical regulators of these processes.
Mackenzie K. Woolls +5 more
wiley +1 more source
Supplementary Figure S1 from Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid ...
Hongyuan Zhou (3451382) +10 more
core +1 more source
Characterisation and Sensitivity of a Canine Mast Cell Tumour Line to Oncolytic Viruses
ABSTRACT Canine mast cell tumours (MCTs) are one of the most common skin cancers of dogs. Surgical removal is the primary treatment, but recurrence and metastasis can occur even with low‐grade tumours. As a result, new treatment strategies are being sought.
Yeganeh Mehrani +11 more
wiley +1 more source
Transformation of Fibroma into Myxoma Virus in Tissue Culture
Summary1. Eleven experiments are described in which fibroma was transformed into myxoma virus in cultures of rabbit tissues, both of testes and of kidneys. 2. The transforming agent (TAM) was myxoma virus inactivated by heating at 65–67°C. 3. Live fibroma virus and TAM were inoculated into tissue cultures simultaneously and TAM was re-added at times of
openaire +2 more sources
Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability [PDF]
To study genetic changes underlying myxoma virus evolution in its new host, the European rabbit (Oryctolagus cuniculus), we sequenced selected genomic regions of nine recent virulent field strains and a live attenuated vaccine strain ("MAV", Germany ...
esteves, pj +15 more
core +1 more source
Construction and testing of a novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is non-permissive for replication in rabbit cells [PDF]
Deletion of the M063 gene from myxoma virus produces a virus that is unable to replicate in rabbit cells in vitro or in live rabbits but can be propagated in non-rabbit cell lines. A targeted M063 deletion mutant was constructed in the attenuated Uriarra
Barbara H. van Leeuwen +7 more
core +2 more sources
Antiviral interferon signalling requires tight regulation to prevent autoinflammation. In humans, ISG15 stabilises the negative regulator USP18. This study reveals that ISG15's role extends beyond stabilisation; its C‐terminal motif facilitates USP18's regulatory function by promoting higher affinity interactions, highlighting ISG15's broader impact on
Andri Vasou +13 more
wiley +1 more source
A myxoma virus intergenic transient dominant selection vector
The purpose of this study was to construct an intergenic transfer vector which can be used for the generation of recombinant myxoma viruses (MVs) expressing a foreign gene insert. Recombinant MVs expressing the Escherichia coli lacZ gene were constructed in vitro by transfection of MV-infected rabbit cells with a transfer expression vector, and ...
R J, Jackson, H G, Bults
openaire +2 more sources
Myxoma virus is a leporipoxvirus that causes a highly lethal virulent disease known as myxomatosis in the European rabbit. An important aspect of myxoma virus pathogenesis is the ability of the virus to productively infect lymphocytes and spread to ...
MACEN, JOANNE L. +5 more
core +1 more source

